Pascal Zufferey

2.3k total citations
75 papers, 1.3k citations indexed

About

Pascal Zufferey is a scholar working on Rheumatology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Pascal Zufferey has authored 75 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 15 papers in Pathology and Forensic Medicine and 13 papers in Surgery. Recurrent topics in Pascal Zufferey's work include Rheumatoid Arthritis Research and Therapies (33 papers), Spondyloarthritis Studies and Treatments (16 papers) and Systemic Lupus Erythematosus Research (12 papers). Pascal Zufferey is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (33 papers), Spondyloarthritis Studies and Treatments (16 papers) and Systemic Lupus Erythematosus Research (12 papers). Pascal Zufferey collaborates with scholars based in Switzerland, United States and France. Pascal Zufferey's co-authors include Axel Finckh, Almut Scherer, Giorgio Tamborrini, Adrian Ciurea, Federico Balagué, Burkhard Möller, Michael J. Nissen, Cem Gabay, Alexander So and Pascale Exer and has published in prestigious journals such as PLoS ONE, Scientific Reports and Spine.

In The Last Decade

Pascal Zufferey

69 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Zufferey Switzerland 22 764 301 263 247 243 75 1.3k
Éric Houvenagel France 20 622 0.8× 227 0.8× 166 0.6× 268 1.1× 188 0.8× 68 1.3k
P Maddison United Kingdom 20 983 1.3× 385 1.3× 357 1.4× 167 0.7× 147 0.6× 38 1.6k
R Kissling Switzerland 25 902 1.2× 372 1.2× 510 1.9× 423 1.7× 214 0.9× 53 1.8k
J. Christiaan van Denderen Netherlands 16 1.8k 2.4× 441 1.5× 223 0.8× 103 0.4× 631 2.6× 26 2.2k
Meltem Alkan Melikoğlu Türkiye 18 401 0.5× 142 0.5× 103 0.4× 142 0.6× 181 0.7× 92 907
C Cervini Italy 22 990 1.3× 113 0.4× 273 1.0× 507 2.1× 178 0.7× 71 1.7k
D L Scott United Kingdom 12 797 1.0× 143 0.5× 94 0.4× 243 1.0× 217 0.9× 15 1.1k
Silje Watterdal Syversen Norway 17 715 0.9× 222 0.7× 71 0.3× 84 0.3× 114 0.5× 39 1.2k
M. Galeazzi Italy 16 359 0.5× 202 0.7× 88 0.3× 148 0.6× 130 0.5× 63 974
Yasser Emad Egypt 18 493 0.6× 256 0.9× 70 0.3× 174 0.7× 154 0.6× 65 1.0k

Countries citing papers authored by Pascal Zufferey

Since Specialization
Citations

This map shows the geographic impact of Pascal Zufferey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Zufferey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Zufferey more than expected).

Fields of papers citing papers by Pascal Zufferey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Zufferey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Zufferey. The network helps show where Pascal Zufferey may publish in the future.

Co-authorship network of co-authors of Pascal Zufferey

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Zufferey. A scholar is included among the top collaborators of Pascal Zufferey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Zufferey. Pascal Zufferey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riek, Myriam, Almut Scherer, Burkhard Möller, et al.. (2023). Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Scientific Reports. 13(1). 17776–17776. 2 indexed citations
2.
Micheroli, Raphael, Christoph Tellenbach, Almut Scherer, et al.. (2020). Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort. Annals of the Rheumatic Diseases. 79(9). 1203–1209. 28 indexed citations
3.
Brulhart, Laure, D. Alpizar-Rodriguez, Pascal Zufferey, et al.. (2019). Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis. RMD Open. 5(2). e000922–e000922. 15 indexed citations
4.
Hebeisen, Monika, Regula Neuenschwander, Almut Scherer, et al.. (2018). Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort. The Journal of Rheumatology. 45(4). 506–512. 24 indexed citations
5.
Molnar, Christoph, Almut Scherer, Xenofon Baraliakos, et al.. (2017). TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Annals of the Rheumatic Diseases. 77(1). 63–69. 186 indexed citations
6.
Zufferey, Pascal, et al.. (2017). [Anti-IL-6 : new therapeutic trends].. PubMed. 13(544-545). 105–109. 1 indexed citations
7.
Alpizar-Rodriguez, D., Laure Brulhart, Ruediger B. Müeller, et al.. (2017). The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis. Clinical Rheumatology. 36(3). 677–682. 17 indexed citations
8.
Zufferey, Pascal, et al.. (2016). [Intra-articular infiltrations in rheumatology: update].. PubMed. 12(500). 90–4.
9.
Zufferey, Pascal, et al.. (2016). Rhumatologie. Infiltrations intra-articulaires en rhumatologie : mise au point. Revue Médicale Suisse. 12(500-01). 90–94. 1 indexed citations
10.
Mach, François, Cem Gabay, Nicolas C. Buchs, et al.. (2015). Consensus guidelines on the cardiovascular risk management in patients with rheumatoid arthritis. Cardiovascular Medicine. 18(4). 127–133. 1 indexed citations
11.
Ruíz-Esquide, Virginia, Pascal Zufferey, Jordi Yagüe, et al.. (2015). OP0032 Relationship Between Clinical Remission and Serum Levels of Tocilizumab in the Treatment of Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 74. 77–77. 1 indexed citations
12.
Zufferey, Pascal & Fabio Becce. (2014). Rôle de l’imagerie dans le diagnostic et le suivi de la polyarthrite rhumatoïde. Revue Médicale Suisse. 10(421). 585–589.
13.
Cornuz, Jacques, et al.. (2013). Epaule douloureuse : prise en charge ambulatoire. Revue Médicale Suisse. 9(408). 2205–2211. 1 indexed citations
14.
Bill, Olivier, Pascal Zufferey, Mohamed Faouzi, & Patrik Michel. (2012). Severe stroke: patient profile and predictors of favorable outcome. Journal of Thrombosis and Haemostasis. 11(1). 92–99. 35 indexed citations
15.
Brulhart, Laure, et al.. (2011). Reproducibility and feasibility of a 22 joints ultrasound score in rheumatoid arthritis: a study among rheumatologists with diverse expertise in musculoskeletal ultrasound. IRIS. 3 indexed citations
16.
Zufferey, Pascal, et al.. (2011). A controlled trial of the benefits of ultrasound-guided steroid injection for shoulder pain. Joint Bone Spine. 79(2). 166–169. 32 indexed citations
17.
Genevay, Stéphane, Axel Finckh, Pascal Zufferey, et al.. (2011). Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial. Annals of the Rheumatic Diseases. 71(4). 560–562. 34 indexed citations
18.
Zufferey, Pascal, et al.. (1999). The role of pattern vision in the development ofcortico‐cortical connections. European Journal of Neuroscience. 11(8). 2669–2688. 44 indexed citations
19.
Zufferey, Pascal, Ariane Boubaker, Angelika Bischof Delaloye, Aaron So, & B Duvoisin. (1999). [Prognostic aspects of scintigraphy and MRI during the first 6 months of reflex sympathetic dystrophy of the distal lower limb: a preliminary prospective study of 4 cases].. PubMed. 80(4). 373–7. 7 indexed citations
20.
Zufferey, Pascal, et al.. (1990). Superior vena cava syndrome due to chronic granulomatous mediastinitis.. SERVAL (Université de Lausanne). 19(4). 341–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Éric Houvenagel Breakdown of academic impact, for papers by P Maddison Breakdown of academic impact, for papers by R Kissling Breakdown of academic impact, for papers by J. Christiaan van Denderen Breakdown of academic impact, for papers by Meltem Alkan Melikoğlu Breakdown of academic impact, for papers by C Cervini Breakdown of academic impact, for papers by D L Scott Breakdown of academic impact, for papers by Silje Watterdal Syversen Breakdown of academic impact, for papers by M. Galeazzi Breakdown of academic impact, for papers by Yasser Emad
Rankless by CCL
2026